Canada to team with California on stem cells

Canada is giving about $98 million to the Canadian Cancer Stem Cell Consortium so that the country's stem cell scientists can work in tandem with the California Institute for Regenerative Medicine. Canadian scientists will work in collaboration with other researchers taking a multi-disciplinary approach to studying stem cell therapies. And Australia's state of Victoria said that it also plans to arrange collaborative projects with CIRM.

"Through this relationship, CIRM money will continue to be earmarked only for research that takes place within California, but we can expand and coordinate our overall efforts in certain areas through collaborative efforts funded by our colleagues in Australia," said Alan Trounson, president of CIRM, in a statement.

- see this release on the partnership
-  read the story from the San Diego Business Journal

Suggested Articles

Bluebird Bio offered the first glimpse of how its CAR-T follow-up is working in multiple myeloma patients who have tried several other treatments.

Zentalis is coming out of stealth with an $85 million series C, which will propel its lead programs into pivotal trials and broaden its pipeline.

The planned takeover centers on ARQ 531, a BTK inhibitor that triggered durable responses in patients with B-cell malignancies.